fashion -WSS

fashion

author：comprehensive 2025-09-27 10:02:50 - browse：96

A vial of Tofersen injection on the left of its box — The ALS drug tofersen is marketed as Qalsody in the U.S. Biogen

LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access to an ALS treatment that’s available in the U.S. and on its way to approval in the European Union.

The medicine in question, Biogen’s tofersen, is designed to treat a rare genetic form of the neurodegenerative disease, accounting for some 2% of all ALS cases. And the issue is how the U.K.’s cost-effectiveness agency has said it would assess the costs and benefits of the therapy.

The agency, the National Institute for Health and Care Excellence, or NICE, has a special pathway for drugs for very rare diseases, which advocates and doctors argue is the route through which tofersen should be reviewed. But NICE has indicated it would review the drug through its standard process, saying it’s because ALS as a whole does not count as a “very rare” disease. That sets a higher bar to clear.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Wikipedia

entertainment

WSS

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

See how much Covid

Letters to First Opinion on caregivers, digital health, and more

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

With trial win, GSK could get blood cancer drug back on market

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

explore

fashion

explore

What does generative AI mean for health care? We asked experts

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Heart attack and stroke risk calculators need revising

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Tori Bowie and the unacceptable rates of Black maternal death

Intellia reports positive results for its CRISPR

Hollywood unions extend contract negotiations for actors

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Change Healthcare can notify patients about the breach, HHS says

Wikipedia

Robert Kennedy Jr.'s presidential campaign attracts GOP

FDA's Pazdur wants cancer trials to range beyond China alone

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Hollywood unions extend contract negotiations for actors

Flagship, Pfizer team up in deal worth up to $7 billion

Innovation in antibiotics is ailing. 'Brain drain' may kill it

leisure time

Wikipedia

entertainment

focus